Category: Procedures

Ask the Expert: How COVID-19 Affects the Eyes

Interviewed by Eric Weintraub, Additional Expertise Contributions by Dr. Brian Toy

With healthcare information changing daily amidst the COVID-19 pandemic, little attention has been given to its effect on one of the most sensitive parts of our bodies: the eyes. To provide an update, Dr. Annie Nguyen, Assistant Professor of Clinical Ophthalmology and Assistant Director of the Cornea & Refractive Surgery Fellowship at the USC Roski Eye Institute, answers frequently asked questions about whether our eyes are vulnerable to the novel coronavirus.

If COVID-19 droplets land in your eye, are you susceptible to infection?

The evidence of ocular transmission has not been well studied. However, mucous membranes, which line many body cavities and organs including the respiratory tract, are most susceptible to the novel coronavirus and viruses in general. The surface of the eye and inner eyelids are also lined by mucous membrane called the conjunctiva. Therefore, if infected droplets land in your eye, you are possibly susceptible to the infection.

The mode of COVID-19 transmission is still believed to be primarily through respiratory droplets from person-to-person. However, the virus can also live on surfaces up to a few days; therefore touching an infected surface, then touching your eyes, noses or mouth without washing your hands may lead to infection.

Can cleaning the eyes with water or over the counter eyedrops decrease the chance of infection?

The ocular surface has its own protective mechanisms, including antimicrobial proteins and natural lubrication. Therefore, routine cleaning or flushing of the eyes with water is not necessary and may actually strip away some of the ocular surface’s natural protective barriers, leading to increased risk of infection.

If your eyes become irritated or red, using over-the-counter artificial tears may help alleviate your symptoms. If symptoms are persistent, you should contact your eye care provider.

Is it true that contact wearers have a higher risk of infection for COVID-19?

With proper hygiene, there is no evidence that wearing contact lenses in itself increases your risk of infection for COVID-19. However, contact lens wearers touch their eyes more often than the average person. If you have a tendency to touch or rub your eyes, it may be best to switch to glasses temporarily, given risk of transmission from rubbing without proper hand hygiene. Also, glasses minimize risk of irritation from contact lens wear and also serve as a barrier that forces you to pause before touching your eyes.

Although not that best protection, glasses can also serve as a partial shield from respiratory droplets. If you do continue contact lens wear, make sure you carefully adhere to contact lens hygiene and wash your hands. If you develop redness or irritation, please discontinue contact lens wear and contact your eye doctor.

Is it true that pink eye is an early sign of COVID-19?

Yes, pinkeye, or conjunctivitis, has been reported to be a possible sign of infection from COVID-19. It is still uncertain exactly what percentage of patients with COVID-19 have ocular manifestations and different sources are reporting different numbers.

Although a recent study in JAMA Ophthalmology reported up to one-third of patients hospitalized with COVID-19 had ocular abnormalities, more studies are still needed. Of course, causes of conjunctivitis that are not COVID-19 related continue to persist.

Can COVID-19 cause temporary or permanent damage to your eyes (perhaps from lack of oxygen)?

Although conjunctivitis, which is a temporary condition, has been linked to COVID-19, at this point permanent eye damage from COVID-19 has not been reported. If a patient were in respiratory distress long enough, theoretically poor perfusion and oxygen deprivation could lead to possible damage to metabolically active tissues, such as the optic nerve or retina, but this has yet to be reported in COVID-19 related cases. In this instance, eye damage would be caused by decreased oxygen, rather than the virus itself.

Can COVID-19 be transmitted through tear droplets and is this something to worry about?

Transmission through infected ocular tissue or fluid has been controversial. Novel coronavirus has been detected in tear samples in a small number of cases. Given the presence of viral particles, it is, therefore, possible to transmit COVID-19, although the risk is likely low. However, the infectivity or clinical significance is not known and additional studies are needed at this time.

What precautions should you take if you are on immunosuppressive medications?

Patients who are immunosuppressed may be more vulnerable to COVID-19 infection, so it is important to adhere to physical distancing measures to minimize risk. Please discuss potential modification of your medication regimen with your physician (uveitis specialist or rheumatologist). In most cases of patients who are not ill, the risk of vision loss from uncontrolled eye inflammation is greater than the possible increased risk of acquiring COVID-19.

Dr. Nguyen closed the interview by reminding us that the COVID-19 situation is always evolving and we are learning more about the virus every day. Please contact your primary care physician if you are experiencing symptoms of COVID-19. If you have irritation or pain in the eye or difficulty seeing, please reach out to an eye care provider.

Dr. Nguyen based much of the information from this interview on what she learned in the following sources:

Cataract Surgery- What to Expect?

This surgery is used to remove a cataract. During the procedure, the cloudy lens in your eye is replaced with an artificial lens that will let you see clearly. This procedure is sometimes called “no-needle, no-stitch” cataract surgery. It’s quick, painless, and you can go home the same day.

When do you need cataract surgery?

Cataracts can be age-related and may occur from the age of 40 and up. Generally visual impairment from age-related cataracts can occur over the age of 60. Cataracts can also form from diseases such as diabetes, through injury or surgery, and even from prolonged exposure to sunlight. If you are experiencing symptoms such as blurred vision, halos or difficulty seeing at night, then it may be time to visit your eye care specialist who will access whether you have cataracts and if you require surgery.

How long does cataract surgery take?

Simple cataract removal can be as short as 10 minutes. However, the procedure may take anywhere from 30-60 minutes as patients need to recover from sedation or anesthesia. Cataract operations are out-patient procedures and patients may go home the same day.

Is cataract surgery painful?

Cataracts are rarely painful. Patients may feel some discomfort and pressure in the eye. Your doctor will prescribe eye drops for the first week following surgery.

How long can you drive after cataract surgery?

Generally patients may drive 24 hours after cataract surgery with full recovery from anesthesia.

How long does it take to recover?

Overall recovery of cataract surgery is typically one week. Be careful not to lift heavy things or getting water directly in the eye for one week. The visual recovery is very quick, most patients see well a day or two after surgery.

Blindness from Cataracts? Five Questions Answered

1. Did you know that cataracts are the leading cause of preventable blindness in the US and even worldwide?

Caused by a clouding of the lens in the eye, cataracts can result in vision loss and have a major impact on quality of life. Cataract-related visual impairment can take away a person’s independence and ability to do every day tasks like drive, cook, or even read.

2. Who is at risk and what are the causes?

Cataracts are not just found in the elderly. Although it may not affect vision at this stage, early signs of cataracts can occur from age 40 and up. Cataracts become progressive and debilitating with age, where almost half of Americans are estimated to have cataracts by the age of 65. Through population-based studies, USC Roski clinicians have also found that a projected 180,000 U.S. Latinos aged 40 and over nationwide have an unmet need for cataract surgery.

Cataracts can be caused by many factors including diseases such as diabetes, exposure to UV light or even smoking and alcohol use. Obesity, high blood pressure, eye injury, or surgery can also result in cataracts.

3. What are the signs?

It is important to recognize the signs. An eye exam is essential if you see halos of light, blurred or poor vision at night, double vision in a single eye or fading yellow of colors. In general, while these symptoms could be related to cataracts, visiting a skilled eye specialist for an evaluation is key to ensuring healthy vision.

4. How to prevent cataracts?

Healthy vision can come from leading a health lifestyle. Quit smoking, eat a well-balanced diet and take care of your health issues by seeing a physician regularly.

5. Cataract surgery – what to expect?

USC Roski cataract surgeons offer the latest advanced technology in cataract extraction. Typically cataract surgery is an outpatient procedure, lasting 30-60 minutes. Cataract surgery entails performing a lens exchange; the surgeon replaces the cloudy cataract lens with a clear lens implant.

In addition to standard lenses, we also offer our patients a large selection of premium lenses that are customizable including, mutifocal, toric and accommodative lenses. USC Roski Eye offers a minimally invasive technique such as femtosecond laser cataract surgery (custom laser cataract surgery) procedure, which allows for more precision in lens removal and gives surgeons the opportunity to treat corneal astigmatism at the time of cataract surgery.

Schedule an Appointment at USC Roski Eye Institute Today

Please contact our USC Roski Eye Institute cataract specialists today if you are experiencing any of the symptoms above. The exceptional eye doctors at USC Roski Eye Institute are experts at diagnosing and treating a wide variety of eye conditions. To receive a comprehensive eye exam and ensure that your vision is protected please complete our online contact form or call 323-442-6335 today!

  • Richter GM et al. Prevalence of Visually Significant Cataract and Factors Associated with Unmet Need for Cataract Surgery: Los Angeles Latino Eye Study. Ophthalmology. 2009, 116: 2327-2335.

Crossed Eyes (Strabismus) – Causes and Treatments – A Q&A with Dr. Patel

Harand before and after

What is Strabismus?

Michael-strab testimonial

Strabismus is a general term used to describe any misalignment of the eyes. It can occur in the context of childhood eye diseases (amblyopia or “lazy eye), or problems acquired in adulthood, including trauma, thyroid eye disease, nerve damage, or neurological disorders. Strabismus can be very debilitating, mainly from double vision. Importantly, strabismus can be an early sign of severe ocular, orbital or neurological disease.

What Causes Crossed Eyes in Children?

In some cases strabismus can be inherited (congenital) or result from vision-related problems. In addition, since approximately half of the brain is involved in vision, certain neurological conditions can also cause strabismus, resulting from disordered communication between the brain and the muscles that move the eyes. Vision in children is highly sensitive to refractive errors (nearsightedness and farsightedness) and may also cause strabismus if left untreated.

What Causes Crossed Eyes in Adults?

Like in children, strabismus in adults can be inherited and may worsen over time. As such, we have helped many adults who have had complications or recurrences despite previous strabismus surgeries in the past. Adult strabismus may also result from neurological conditions such as stroke, tumors, degenerative diseases such as Parkinson’s, to name a few. We specialize in evaluating the nature and cause of strabismus in adults, as well as developing an appropriate plan for intervention.

What Treatments are Available for Strabismus?

Strab before and after 2
Children and adults may be treated differently. In children, strabismus can often be corrected using eye patching, eyeglasses, vision therapy and surgery. In adults, special lenses such as prisms can correct or improve double vision in some cases; however, surgery may also be required to correct the misalignment. Over the past few decades, strabismus surgery has advanced considerably. Here at USC we have the necessary experience and expertise to address even the most complex cases, using the latest techniques and up-to-date practices.

USC Roski Eye Institute Neuro-Ophthalmology and Adult Strabismus Service


Vivek R. Patel, MD, is an Associate Professor of Clinical Ophthalmology, Director of Neuro-Ophthalmology Service and Adult Strabismus specialist. He is also co-principal investigator for a $4 million grant from the National Eye Institute (NEI), leading a multidisciplinary team of investigators studying the relationship between the brain and blinding eye diseases.

Gokoffski website final

Kimberly K. Gokoffski, MD, PhD, is an Assistant Professor of Ophthalmology and Adult Strabismus specialist. Her doctoral work and current active research investigations focus on exploring the use of electrical fields to guide regenerating nerves in the context of optic nerve disease. She is funded by the NEI’s K-grant system of mentored original research.

Schedule an Appointment at USC Roski Eye Institute Today

Please contact our USC Roski adult strabismus team today to treat misalignment of your eyes or double vision. The exceptional eye doctors at USC Roski Eye Institute are experts at diagnosing and treating a wide variety of eye conditions. To receive a comprehensive eye exam and ensure that your vision is protected please complete our online contact form or call 323-442-6335 today!

To learn more about a new funding initiative for children’s strabismus surgery or for donations, please contact Rebecca Melville, senior director of development, via email at or by calling USC Roski Eye Institute.

USC Roski Eye Institute Researchers Report First Results in Stem Cell-Based Clinical Trial for Dry Age-Related Macular Degeneration


Researchers, clinicians, scientists from the USC Roski Eye Institute and collaborators report encouraging results of a first-in-kind stem-cell based implant in a featured article in Science Translational Medicine entitled, “A Bioengineered Retinal Pigment Epithelial Monolayer for Advanced, Dry Age-Related Macular Degeneration.”

The novel minimally invasive stem cell-based therapy for dry age-related macular degeneration (AMD) was developed by a team at USC Roski Eye Institute, led by Mark S. Humayun MD, PhD, and David R. Hinton, MD, which was funded by the California Institute for Regenerative Medicine. The implant consists of stem cell-derived retinal pigment epithelium cells (RPE) on an ultrathin synthetic substrate. The implanted scaffold of RPE are localized and can function to support and replenish light sensing cells of the eye, which would help restore and prevent vision loss in patients with AMD.

“This is the first human trial of this novel stem cell–based implant, which is designed to replace a single-cell layer that degenerates in patients with dry age-related macular degeneration,” says lead author and surgeon for the study Amir H. Kashani, MD, PhD, assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. “This implant has the potential to stop the progression of the disease or even improve patients’ vision. Proving its safety in humans is the first step in accomplishing that goal.”

Photo courtesy of Britney O. Pennington, PhD
Photo courtesy of Britney O. Pennington, PhD

The first results of the phase I/IIa clinical trial conducted at the USC Roski Eye Institute has been reported on four patients which were followed up to one year to assess safety. It was determined that the implant is safe and integrates well with the patient’s retinal tissue. One patient had improvement in visual acuity by up to 17 letters and two patients had gains in visual function, which was measured by how well they could use the area of the retina treated by the implant. None of the patients showed evidence of progression in vision loss.

Dry AMD can have a profound affect on the quality of life of an individual. In time as the disease progresses, patients will be unable to recognize faces, read or even drive. It is projected that over 3 million will be diagnosed with dry AMD by 2020.

“Our study shows that this unique stem cell–based retinal implant thus far is well-tolerated, and preliminary results suggest it may help people with advanced dry age-related macular degeneration,” says coauthor and lead inventor of the implant Mark S. Humayun, MD, PhD, director of the USC Institute for Biomedical Therapeutics, co-director of the USC Roski Eye Institute, affiliate principal investigator with the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC and University Professor of Ophthalmology at the Keck School.

Stem Cell AMD blog final
Other USC researchers include Biju B. Thomas, PhD; Debbie Mitra, PhD; and Danhong Zhu, MD, PhD.

Collaborating institutions for the study include Regenerative Patch Technologies LLC, which also contributed to the funding of the study, as well as Camtek LLC, the California Institute of Technology, Retina Vitreous Associates Medical Group, California Retina Consultants, Atlantis Eyecare, City of Hope, University of California, Santa Barbara and Denney Research Center. Additional sources of funding for the study include Lori Mars and David Fields Gift, Estate of Beatrice Apple, William K. Bowes Foundation, Vermont Community Foundation, Breaux Foundation, Wilcox Family Foundation and Research to Prevent Blindness.

For more information about the study, visit To participate in the study, please call (323) 442-6335.


Disclosures: Regenerative Patch Technologies LLC was founded by Mark Humayun, MD, PhD, and David R. Hinton, MD, from Keck Medicine of USC and Dennis O. Clegg, PhD, from the University of California, Santa Barbara. The technology to produce the stem cell–based retinal implant is exclusively licensed to Regenerative Patch Technologies LLC from the University of Southern California, the California Institute of Technology and the University of California, Santa Barbara. Humayun and Hinton have an equity interest in and are consultants for Regenerative Patch Technologies LLC.

Model Risks Losing Eye after Tattooing it Purple

A model in Ottawa, Canada made the decision to tattoo her eye purple, as it was her favorite color. Very quickly she realized something was wrong when the purple ink began to leak from the white part of her eye. Experiencing excruciating pain, her eye began to swell and become infected.

In recent years, the procedure of scleral staining or episcleral tattooing has become an emerging trend. The sclera is the white outer layer of the eye. It is significantly more porous and thinner than skin. As a consequence, these dyes and inks can easily diffuse through the sclera and reach the fragile visual processing structures inside the eye. According to a report in 2015, episcleral tattooing can result in headaches or photophobia (light sensitivity) to more severe complications like infection, hemorrhage or even direct penetration into the eyeball.

Photo: Catt Gallinger
Photo: Catt Gallinger

“Eye tattooing is not recommended as it is very dangerous and can cause serious complications. Once inside the eye, these chemicals will wreak havoc because of their innate toxicity and will most certainly lead to devastating visual loss,” says Charles W. Flowers, Jr. MD, Associate Professor of Clinical Ophthalmology at the USC Roski Eye Institute.

The ophthalmologist who treated model Catt Gallinger, observed a scleral tear from the large needle used to stain her eye as well as a severe infection. Gallinger received grafts and has permanent vision loss from this procedure.

Having posted multiple times on Facebook, Gallinger has brought greater awareness to the dangers of undergoing episcleral tattooing.

Schedule an Appointment at USC Roski Eye Institute Today

The exceptional eye doctors at USC Roski Eye Institute are experts at diagnosing and treating a wide variety of eye conditions. To receive a comprehensive eye exam and ensure that your vision is protected, please complete our online contact form or call 323-442-6335 today!

To learn more about the health services at the USC Roski Eye Institute or to support the Institute with a tax-deductible gift, please contact Rebecca Melville, executive director of development, via email at or by calling USC Roski Eye Institute.

By: Debbie Mitra, PhD


USC Roski Eye Institute Helps Blind Patient Regain Sight with Two Retinal Implants

Terry Byland and his wife Sue, just before his surgery to implant an Argus II prosthetic device in his left eye.When USC Roski Eye Institute patient Terry Byland fully lost his sight to retinitis pigmentosa at age 45, he never could have imagined what his future had in store. Byland recently became the first person in the world to have to retinal prostheses implanted – one in each eye – restoring some sight and much-needed independence.

“I just can’t get over what I can see, and all the things I’ve seen so far,” Byland said.

The 66-year-old Riverside resident began his journey toward regaining his sight when he participated in a clinical trial for the original retinal prostheses, the Argus I, between 2004 and 2010. The 16-electrode artificial retina was implanted in his right eye on June 23, 2004.

Participating in the initial trial gave Byland new purpose after struggling with not only retiring early and giving up the job he loved, but also losing out on getting to watch his children grow up.

“Terry is a true pioneer,” said Mark Humayun, M.D., Ph.D., co-inventor of the device, who holds joint appointments at the Keck School of Medicine of USC and the USC Viterbi School of Engineering. “His work with the first-generation implant helped our team develop the FDA-approved Argus II. For him to enjoy the benefit of this smaller, better device is gratifying.”

On June 22, 2015, Byland received the new 60-electrode Argus II implant by Lisa Olmos de Koo, M.D. at the USC Roski Eye Institute. The Argus II is equipped with software that can be updated as new image processing technology becomes available, allowing Byland to have new features introduced to continually improve his sight.

Combining Medicine and Engineering

The Argus II is revolutionary in that it helps patients identify large letters as well as locate objects using a small video camera, which is mounted to a pair of eyeglasses. The video processing unit then transforms the images picked up by the camera into electronic signals that are wirelessly transmitted to the implant. The prosthesis stimulates visual neurons that send the signals through the optic nerve to the brain, which are interpreted as a visual image.

“The prosthesis allows more independence. And the more independent you are, the happier you are,” said Byland.

The Argus II is the groundbreaking success of a close collaboration between USC Roski Eye Institute, Keck School of Medicine of USC, and USC Viterbi School of Engineering. The device is designed to help patients who have suffered blindness as a result of an inherited retinal degenerative disease called retinitis pigmentosa.

Contact an Innovative Ophthalmology Team

The Argus II is available to qualifying patients at the Keck Medical Center of USC. It is important to receive a thorough eye exam from a professional optometrist or ophthalmologist to catch vision problems and get effective treatment. Please do not wait to make an appointment with a skilled ophthalmologist at USC Roski Eye Institute for a comprehensive eye exam using the most state-of-the-art technology available.

Help support our research and innovation by making a tax-deductible gift by contacting Rebecca Melville, senior director of development, at 323.442.5396 or via email at today!


How Reliable are Online Eye Exams?

USC Residency Exam Department of OphthalmologyAt a time when more people turn to the internet for everything, from information to shopping to making a living, it is not surprising that the concept of “telemedicine” has become more of a reality each day. Now, psychiatric patients can have Skype therapy sessions from the comfort of home, monthly medication prescriptions can be refilled with the click of a mouse, and even an eye exam can be performed with just a laptop and a smartphone. But for all the convenience and efficiency that telecommunication and information technology has brought to our lives, how well can it replace the thoroughness and expertise of a doctor’s appointment?

What Do Online Eye Exam Companies Promise?

One online company in particular, Opternative, has come under scrutiny recently for claiming to offer refractive eye exams that are just as accurate as an in-person exam with an optometrist. Needless to say, the claim drew the attention of the American Optometric Association (AOA), an organization that represents nearly 40,000 optometrists, optometry students, and paraoptometric technicians and assistants, as well as the American Academy of Ophthalmology (AAO), the largest national membership association of ophthalmologists, osteopathic doctors, and medical doctors in the country.

According to Opternative, in order to take the online refractive eye exam, a patient needs to be between the ages of 18 and 40 and have access to a computer and a smartphone. Following a series of online visual tests and multiple choice questions, the patient’s results are then sent to a physician to approve or deny the patient’s glasses or contact lens prescriptions within at least 24 hours. Based on Opternative’s own clinical study, the results of the online refractive test are just as accurate as a traditional exam and only use technology that has already been approved by the U.S. Food and Drug Administration.

Both the AOA and AAO have openly challenged the online company, stating that Opternative’s claims are misleading to consumers because they highlight convenience, low costs, and FDA approval without providing adequate information about the limitations of the test.

Important Factors to Consider When Taking an Online Vision Test

In order to help the public more accurately evaluate online eye exams, the AAO has issued the following guidelines.

  • First, an online test is not a substitute for a one-on-one eye exam. It may be used as a follow-up tool for patients between the ages of 18 and 39 who do not need severe corrective eyeglasses.
  • If you experience vision problems, schedule an appointment with an ophthalmologist.
  • Patients under 18 years of age or 40 and older should not rely on online eye exams. Instead, they should visit a qualified ophthalmologist or optometrist who can identify risk factors or symptoms of eye disease and begin treatment as soon as possible.
  • Patients between the ages of 18 and 39 should schedule comprehensive eye exams every five to 10 years to detect eye diseases and conditions such as glaucoma, cataracts, or corneal astigmatism that may not present immediate symptoms.
  • Online vision tests cannot offer accurate prescriptions for patients that need irregular or high-power prescriptions.
  • Online vision tests can test the power of eyeglass prescriptions, but are not effective at testing contact lens prescriptions.

Schedule an Eye Exam at USC Roski Eye Institute

Regular, annual eye exams from a professional optometrist or ophthalmologist are the only way to accurately catch vision problems and get effective treatment. An online eye exam may be appealing for its convenience, but it is important that patients are fully aware of the limitations. Please do not wait to make an appointment with a skilled ophthalmologist at USC Roski Eye Institute for a comprehensive eye exam using the most state-of-the-art technology available.

Support the USC Roski Eye Institute by making a tax-deductible gift by contacting Rebecca Melville, senior director of development, at 323.442.5396 or via email at today!

Next, read What Toll is the Sun Taking on Your Eyes

PROSE Treatment Brings Relief to Cancer Survivor

USC Eye PROSE Treatment
“I had lost all hope until I came to the USC Roski Eye Institute. I’m excited about the PROSE treatment because it will take care of my pain so that I can live a normal life.” – Nicole Schultz, USC Roski Eye Institute patient

Nicole Schultz, a two-time cancer survivor, has been suffering from the devastating effects of a condition known as ocular graft-versus-host disease (GvHD).

Medical and Ocular History

Schultz was diagnosed with ocular GvHD following her second bone marrow transplant, which she received during her cancer treatment. Serious complications can arise in patients with GvHD, when donor cells from transplants attack connective tissue of the patient or host. For Schultz, GvHD manifested in her eyes, which were no longer able to produce tears and resulted in painful flare-ups. For years she sought treatment for dry eye, visiting many doctors, who prescribed various eye drops and even punctal plugs to increase tears and moisture in her eyes. Schultz’s life changed dramatically, since she was required to administer drops multiple times a day to diminish the pain she experienced. She says she was on the verge of giving up hope when it was suggested to visit the USC Roski Eye Institute to try a unique contact lens treatment option known as prosthetic replacement of the ocular surface ecosystem (PROSE).

Gloria Chiu, OD, FAAO Assistant Professor of Clinical Ophthalmology and Chief Optometrist Specialty: PROSE and Specialty Contact Lens
Gloria Chiu, OD, FAAO, FSLS, Assistant Professor of Clinical Ophthalmology and Chief Optometrist
Specialty: PROSE and Specialty Contact Lens

After meeting Schultz for the first time, Gloria Chiu, OD, FAAO, FSLS, who is trained in PROSE treatment, immediately knew that she could help relieve Schultz’s symptoms.

PROSE treatment, a non-surgical procedure, is offered to patients who suffer from serious corneal conditions and ocular surface diseases. PROSE therapy reduces symptoms, supports healing and improves vision through the use of a prosthetic scleral device that is tailored for each individual. Schultz is also using non-preserved artificial tears with PROSE therapy to enhance comfort and fit.

Recent studies have demonstrated that patients who received this pioneering treatment experienced a notable improvement in their quality of vision and quality of life as a result.

The USC Roski Eye Institute is the third of 12 sites in the nation to offer PROSE technology to our patients. Chiu is one of only two West Coast eye care providers to offer PROSE treatment.


“It is a privilege to be able to provide Nicole with a treatment that can quite simply change her life. These custom devices help to improve her vision, comfort and assist in the healing of her ocular surface,” says Chiu.

For more information on PROSE treatment, please visit

Join the USC Roski Eye Institute in its quest to preserve, protect and restore the gift of sight by making your tax-deductible donation today. Thank you for your support! GIVETO.USC.EDU/EYE

Next, read about Ophthalmic Services Provided to Special Olympic Athletes